{"id":"W2980074380","doi":"10.1182/blood.v128.22.2273.2273","title":"Bortezomib-High Dose Melphalan Conditioning for the Treatment of MM Patients Undergoing ASCT","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"Alberta Health Services; Institute of Cancer Research; University of Calgary","funders":"","keywords":"Medicine; Melphalan; Bortezomib; Internal medicine; Regimen; Autologous stem-cell transplantation; Urology; Surgery; Oncology; Chemotherapy; Multiple myeloma","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003213501,0.000144242,0.0004208456,0.0002358251,0.0002724493,0.0002758108,0.0001290219,0.0001888439,0.001032144],"category_scores_gemma":[0.0004587168,0.00007612476,0.000215723,0.0002745418,0.0001704763,0.0001372185,0.0001567344,0.0002770868,0.0001418331],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002471633,"about_ca_system_score_gemma":0.0004917174,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003168151,"about_ca_topic_score_gemma":0.0006318866,"domain_scores_codex":[0.9998233,0.00007010437,0.00002249416,0.00002579313,0.00002644038,0.00003191131],"domain_scores_gemma":[0.9997581,0.00004927562,0.00007069988,0.00001139257,0.00001706412,0.00009354902],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.008696814,0.0006505396,0.9040192,0.000171678,0.0001160852,0.001733902,0.0001272317,0.0005191448,0.02029261,0.00009843589,0.0009393083,0.0626351],"study_design_scores_gemma":[0.000532432,0.01536231,0.966397,0.00008314376,0.0001379966,0.00670388,0.0001226621,0.000980624,0.004958199,0.0001488355,0.004559851,0.00001308317],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9969469,0.00187012,0.0001513473,0.0001031725,0.00001730225,0.00005649033,0.000118331,0.000006202819,0.000730163],"genre_scores_gemma":[0.9986639,0.0004854663,0.000350326,0.00007519231,0.00005293504,0.00003337807,0.0001925676,0.000001311961,0.0001449399],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001032144,"threshold_uncertainty_score":0.003452837,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02671847572376897,"score_gpt":0.3007419932063832,"score_spread":0.2740235174826143,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}